A trusted source of innovative orthopedic solutions that improve patient outcomes, increase healthcare efficiencies, and enhance the surgeon experience
Exodus applies financial and human capital along with deep industry experience towards innovative orthopedic technologies to rapidly execute development, commercialize with excellence and exit, delivering significant value to our industry partners and shareholders
OUR CORE VALUES
THE FOUNDATION
OF INNOVATION
At Exodus New Ventures, our values guide our diverse portfolio of orthopedic innovations.
Compassion
We will take appropriate risks and be willing to accept failures while always prioritizing the well-being of our employees and the patients and surgeons that we serve with our solutions.
Integrity
We uphold the highest ethical standards in all our ventures, both internally and with the external partners we work with.
Collaboration
Business is a team endeavor. We foster partnerships within and across our venture portfolio, encouraging knowledge sharing between industry and orthopedic surgeons to create comprehensive solutions.
Execution
Action is the basis for success. We efficiently transform innovative concepts into commercially ready and clinically proven solutions.
WHERE WE'VE BEEN
Rich History of Demonstrated Success
Combined Exit Values
$0M+
Patents
0+
510(k)s
0+
Product Launches
0+
ORTHOPEDIC INNOVATION
ACTIVE VENTURES
Our active ventures represent the cutting edge of orthopedic technology, addressing key challenges in patient care and surgical precision.
Scientific Motion Technologies
Scientific Motion Technologies is developing and commercializing a clinically proven, non-invasive therapy to address knee pain in both preoperative and postoperative patients.
A hardware and software focused company, ODI is developing a novel solution leveraging digital fluoroscopy technology to provide 2D and 3D imaging for active surgical guidance.
Orthopedic Driven Imaging (ODI)
ArthroTAK
ArthroTAK is a new, sutureless tendon anchor system designed to efficiently and effectively attach biologic and synthetic tendons to bone.
JPD is developing imaging capabilities that allow identification and quantification of cartilage damage in various joints.